Yes this was pumped and dumped for sure, but without the knowledge of the CEO of company, in my opinion. He was trashed to no end back when this stock was P'd and D'd and in my opinion it was unwarranted. I have had contact with him recently. They are still in business and according to him does not know why the stock has cycled up to 10 cents and back to cents lately. He said he is trying to get the stock back on a trading board through FINRA, etc.
Here is an email I received from the CEO recently. I'm sure you must have received it to. Below that email you will see a response from Dr. Cappello to my email inquiry/advice regarding their referral marketing program referred to. I provide it just to show you that I do have personal contact with him and have had so since the stock was manipulated.
By the way you are doing better than me. I have 2200 shares with ave. price of $1.86, even though I have less invested than you do dollar wise. I think they have some quality products and is why I invested in the first place. If they can get them off the ground and get their reputation back, we could have a sleeping giant here. I have some respect for the CEO for enduring a lot of heat and some pretty nasty and unfounded accusations from people on this board that I'm sure came from the shorts. I followed it very closely at the time and was able to disprove most of the accusations. I will admit at times I was swayed in the direction of the bashers. I had direct contact with DR. Cappello during that entire time and he really acted like a stand up guy. Here are the emails:
============================
----- Original Message ----- From: John Cappello To: John Cappello Sent: Thursday, November 11, 2010 7:32 AM Subject: EMGE Sept-Oct 2010 Update
Dear Subscriber,
We wish to report the following items to you.
1. Our sales for the nine months of 2010 exceeded sales of the same period 2009 by about 6% despite much of our attention still being directed to clearing ourselves with the SEC, which was completed in July 2010.
2. Our Balance Sheet reached its highest levels since inception and was above $400,000 in assets for the first time We have no debt.
3. We remain profitable to this point.
4. We have responded to the first round of FINRA comments we received September 2, 2010 to resume trading. Our answers were sent on October 29, 2010. We await a second round of comments and will continue our efforts to assist shareholders with a better market for their shares.
5. Vita-Stim has been approved by the Ministry of Health in Cambodia, and we expect to see sales there and other S.E. Asia countries increase over time.
6. The Vita-Stim Infomercial continues to run, and it has been a good test for forward thinking and planning.
7. Our licensor has had its hair growth patent allowed, and we are reviewing plans.
We continue to believe that press releases will do little until we have been given electronic trading privileges, as we had prior to our trading halt. We have chosen this method to keep all informed.
Here are some Investment quotes:
"We are not a stock that you can sleep well with at night. We are a volatile stock. At the same time, someone's sitting in the shade today because someone planted a tree a long time ago. We believe, we are that 'tree'."
We appreciate your ongoing good will and support.
Sincerely,
Emergent Health Corp.
This Newsletter contains certain "forward-looking" statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements.. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the company.
This Newsletter is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.
========================
Below is Dr. Cappello's response to my email regarding the proposed referral marketing program. By the way, I also asked him about why the stack was trading between .02 and .010, because I saw this and was going to try and play that spread, but I couldn't buy any shares. I put orders in through TD Ameritrade, but they would never go through.
===========================
----- Original Message ----- From: John Cappello To: Pillows For Soldiers Sent: Thursday, November 11, 2010 4:52 PM Subject: Re: EMGE Sept-Oct 2010 Update
Hi Dave,
Nothing you saw is engraved in stone...the one video is designed to go to a product information link, and I just did not want to go over too much detail yet. As far as price, that is just an example. The ideas on all of our breakthroughs is to make them affordable....and EMGE is not going into the networking business per se....we are providing product to a new company with experienced networking people.....
Vita-Stim moves very well in stores for $39.95....it is not the cheapest product to put together in still low volume runs.... economies of scale will help us....and shareholders do not want to see us bleed money in the building process.
I have been told by people who have bids in all of the time for stock at $0.10 to $0.15...and can not pick any up...yet it sometimes nosedives with no explanation....I even called FINRA and could get no answers as they said "trading on the grey market is proprietary. The view I am hearing is many want to average down, but they can not...who knows what will happen in tax loss selling season!!!!